Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2005

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • IRIS [Innohep® in Renal Insufficiency Study] (4 documents)
Loading references information
The objective of the study is to compare the safety of innohep® and Unfractionated Heparin (UFH) in terms of clinically relevant bleedings in elderly patients with impaired renal function for initial treatment of acute Deep Venous Thrombosis (DVT).

The primary response criterion is the percentage of patients with clinically relevant bleeding events prior to day 90 +/- 5.
Epistemonikos ID: 51b455680b85ea44cd9299fc87fecbe2fe7b4172
First added on: Mar 03, 2017